Investors
Press Releases
Press releases issued by Palatin are accessible below. These press releases contain additional information about our business, clinical trial developments, research and development activities, financial achievements, and strategic partnerships.
Found 310 Results
Palatin Technologies Announces $9.25 Million Financing
August 1, 2016
Palatin Technologies Receives Patent Strengthening Its Melanocortin Peptide Intellectual Property
June 6, 2016
Palatin Technologies Receives Patent Strengthening Its Melanocortin Peptide Intellectual Property
May 26, 2016
Palatin Technologies Presents Bremelanotide Alcohol Interaction Study at International Society for the Study of Women’s Sexual Health Annual Meeting
February 26, 2016